Phase 2 Ovarian Cancer Trial, Recruiting NCT06152731 Sponsor: Centre Francois Baclesse Condition: Ovarian Cancer
Back to Ovarian Cancer

Phase 2 Ovarian Cancer Trial, Recruiting

NCT06152731
Recruiting Phase 2

voxsanity.com.au · Eligibility summary from public government registries · 18 August 2026 · not medical advice

Who may and may not be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who may be able to join

  • People aged 18 years or older
  • People who have been diagnosed with high-grade serous ovarian cancer, fallopian tube cancer, or peritoneal cancer, confirmed through a tissue test
  • People who have been newly diagnosed with advanced-stage disease (stage III or IV) and are being considered for first-line platinum-based chemotherapy as their initial treatment
  • People who have a tumour tissue sample available for genetic testing — ideally collected before chemotherapy begins, and meeting minimum size and cell content requirements
  • People who are enrolled in an appropriate social security or health insurance system
  • People who have signed a consent form before any trial-related activities take place

Who may not be able to join

Each point below is a reason the trial team may not be able to accept someone. It is not a list of requirements to meet.

  • People whose ovarian, fallopian tube, or peritoneal cancer has come back after a previous diagnosis (recurrent cancer)
  • People with a type of ovarian cancer that is non-epithelial or classified as borderline
  • People who have another cancer diagnosis that could interfere with treatment for ovarian cancer or significantly affect their outlook
  • People whose care is being managed in a purely palliative (end-of-life comfort care only) setting
  • People who are under legal guardianship or have had their personal freedoms restricted by a court order

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 31 July 2026

If this is close to home

This page includes language about advanced illness, prognosis, or palliative care, because that is how the trial's eligibility criteria are written. Seeing it set out plainly can land hard, whether it is about you or about someone you are caring for. You do not have to be at a crisis point to talk to someone.

  • Griefline — grief and loss counselling, 9am to 6pm weekdays and midday to 6pm weekends (AEST/AEDT): 1300 845 745
  • Carer Gateway — practical and emotional support if you are caring for someone, 8am to 5pm weekdays: 1800 422 737
  • Canteen — for 12 to 25 year olds affected by cancer, their own or a family member's: 1800 945 215
  • Palliative Care Australia — directory of palliative care services near you: palliativecare.org.au
  • Lifeline — 24/7, for any kind of distress, at any hour the services above are closed: 13 11 14

Palliative care is not the same as giving up on treatment, and it is not only for the last weeks of life. It is symptom and comfort care that can run alongside active treatment, including a clinical trial.

Outside Australia? The numbers above are Australian and will not work from overseas. Find a Helpline is a free directory of support and crisis lines in over 130 countries, run by ThroughLine with the International Association for Suicide Prevention.

Voxsanity is not a counselling or medical service, and nothing on this page is medical advice. More Australian services are listed on our support lines page.

Contact this trial

Phone: 33231455050

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Phase 2
Sponsor
Centre Francois Baclesse
Registry
ClinicalTrials.gov
Start date
15 February 2024
Est. completion
1 June 2031

Where this trial is recruiting

🇫🇷 France

Primary endpoints

Rate of platinum-sensitive ovarian cancer patients according to GIScar HRD signature (classified into HRD or HRP).

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 31 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov